| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Encephalomyelitis, Autoimmune, Experimental | 115 | 2023 | 822 | 11.380 |
Why?
|
| Th17 Cells | 47 | 2023 | 791 | 9.120 |
Why?
|
| Autoimmunity | 62 | 2023 | 1361 | 6.850 |
Why?
|
| Interleukin-17 | 54 | 2023 | 924 | 6.150 |
Why?
|
| T-Lymphocytes, Regulatory | 83 | 2022 | 3114 | 5.780 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 47 | 2021 | 977 | 5.600 |
Why?
|
| Th1 Cells | 43 | 2023 | 1042 | 5.010 |
Why?
|
| T-Lymphocyte Subsets | 46 | 2023 | 1815 | 4.550 |
Why?
|
| Autoimmune Diseases | 44 | 2023 | 2257 | 4.290 |
Why?
|
| Receptors, Virus | 36 | 2016 | 652 | 4.080 |
Why?
|
| T-Lymphocytes | 103 | 2023 | 10266 | 3.890 |
Why?
|
| Interleukin-10 | 39 | 2022 | 1183 | 3.890 |
Why?
|
| Interleukins | 21 | 2023 | 796 | 3.440 |
Why?
|
| Lymphocyte Activation | 94 | 2023 | 5505 | 3.420 |
Why?
|
| Cell Differentiation | 77 | 2023 | 11669 | 3.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 42 | 2022 | 4415 | 2.800 |
Why?
|
| Myelin Proteolipid Protein | 35 | 2011 | 107 | 2.770 |
Why?
|
| Receptors, Immunologic | 17 | 2020 | 1418 | 2.760 |
Why?
|
| Receptors, Interleukin | 16 | 2022 | 243 | 2.570 |
Why?
|
| Membrane Proteins | 51 | 2023 | 7876 | 2.540 |
Why?
|
| Th2 Cells | 24 | 2019 | 1078 | 2.470 |
Why?
|
| Inflammation | 43 | 2023 | 10873 | 2.300 |
Why?
|
| Mice | 298 | 2023 | 82029 | 2.190 |
Why?
|
| Animals | 372 | 2023 | 169246 | 2.120 |
Why?
|
| Galectins | 17 | 2014 | 295 | 1.960 |
Why?
|
| Mice, Inbred C57BL | 129 | 2023 | 22379 | 1.940 |
Why?
|
| Cytokines | 69 | 2023 | 7453 | 1.940 |
Why?
|
| Immune Tolerance | 38 | 2019 | 2323 | 1.910 |
Why?
|
| Interleukin-23 | 17 | 2022 | 202 | 1.820 |
Why?
|
| Forkhead Transcription Factors | 28 | 2017 | 1625 | 1.810 |
Why?
|
| Multiple Sclerosis | 31 | 2022 | 3250 | 1.770 |
Why?
|
| Autoantigens | 20 | 2019 | 890 | 1.700 |
Why?
|
| B-Lymphocytes | 15 | 2023 | 4793 | 1.600 |
Why?
|
| Antigens, CD | 35 | 2021 | 4035 | 1.600 |
Why?
|
| Receptors, Antigen, T-Cell | 37 | 2021 | 2568 | 1.560 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 15 | 2013 | 897 | 1.560 |
Why?
|
| CD8-Positive T-Lymphocytes | 23 | 2023 | 4648 | 1.550 |
Why?
|
| Gene Regulatory Networks | 8 | 2020 | 1752 | 1.500 |
Why?
|
| Antigen-Presenting Cells | 17 | 2012 | 960 | 1.490 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 22 | 2011 | 812 | 1.370 |
Why?
|
| Lymphocytes | 4 | 2023 | 2614 | 1.310 |
Why?
|
| Mice, Knockout | 72 | 2023 | 14488 | 1.280 |
Why?
|
| Peptide Fragments | 40 | 2020 | 5151 | 1.260 |
Why?
|
| Mice, Transgenic | 67 | 2023 | 9561 | 1.240 |
Why?
|
| Membrane Glycoproteins | 26 | 2014 | 3711 | 1.200 |
Why?
|
| Colitis | 10 | 2022 | 1242 | 1.190 |
Why?
|
| Interleukin-2 | 18 | 2019 | 1895 | 1.170 |
Why?
|
| Myelin Proteins | 22 | 2009 | 212 | 1.090 |
Why?
|
| Signal Transduction | 58 | 2020 | 23645 | 1.090 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 10 | 2016 | 151 | 1.080 |
Why?
|
| Interferon-gamma | 38 | 2021 | 3160 | 1.060 |
Why?
|
| Gene Expression Regulation | 32 | 2019 | 11928 | 1.040 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 3 | 2017 | 153 | 1.020 |
Why?
|
| Proto-Oncogene Proteins c-maf | 5 | 2018 | 69 | 1.010 |
Why?
|
| Autoantibodies | 14 | 2020 | 2121 | 0.960 |
Why?
|
| Transforming Growth Factor beta | 22 | 2017 | 1996 | 0.960 |
Why?
|
| Neuropeptides | 3 | 2019 | 951 | 0.940 |
Why?
|
| STAT1 Transcription Factor | 6 | 2018 | 343 | 0.930 |
Why?
|
| Molecular Chaperones | 3 | 2022 | 762 | 0.930 |
Why?
|
| Fibrinogen | 2 | 2020 | 891 | 0.910 |
Why?
|
| Dendritic Cells | 16 | 2023 | 2747 | 0.890 |
Why?
|
| Antigens, Differentiation | 10 | 2005 | 921 | 0.850 |
Why?
|
| Cells, Cultured | 50 | 2019 | 19015 | 0.840 |
Why?
|
| Amino Acid Sequence | 60 | 2018 | 13421 | 0.840 |
Why?
|
| Myelin-Associated Glycoprotein | 11 | 2009 | 110 | 0.830 |
Why?
|
| Central Nervous System | 15 | 2023 | 1346 | 0.820 |
Why?
|
| Ribonucleoproteins | 12 | 2018 | 359 | 0.800 |
Why?
|
| Interleukin-4 | 16 | 2022 | 1156 | 0.800 |
Why?
|
| Intestines | 5 | 2021 | 1909 | 0.790 |
Why?
|
| Ligands | 25 | 2019 | 3284 | 0.780 |
Why?
|
| Immunity, Innate | 17 | 2023 | 3080 | 0.770 |
Why?
|
| Antibodies, Monoclonal | 38 | 2023 | 9263 | 0.760 |
Why?
|
| Molecular Sequence Data | 59 | 2015 | 17622 | 0.750 |
Why?
|
| Major Histocompatibility Complex | 10 | 2012 | 877 | 0.740 |
Why?
|
| Transcription Factors | 19 | 2021 | 12168 | 0.740 |
Why?
|
| Adoptive Transfer | 25 | 2015 | 825 | 0.720 |
Why?
|
| Antibody Formation | 7 | 2020 | 1393 | 0.720 |
Why?
|
| Organ Specificity | 4 | 2021 | 1968 | 0.710 |
Why?
|
| Calcitonin Gene-Related Peptide | 3 | 2019 | 328 | 0.710 |
Why?
|
| STAT3 Transcription Factor | 12 | 2018 | 874 | 0.710 |
Why?
|
| B-Lymphocyte Subsets | 4 | 2017 | 241 | 0.700 |
Why?
|
| Apoptosis Regulatory Proteins | 8 | 2015 | 1151 | 0.700 |
Why?
|
| Neoplasms | 12 | 2023 | 22371 | 0.690 |
Why?
|
| Diabetes Mellitus, Type 1 | 14 | 2015 | 3447 | 0.670 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2019 | 31 | 0.670 |
Why?
|
| Interleukin-21 Receptor alpha Subunit | 3 | 2016 | 18 | 0.650 |
Why?
|
| Mucus | 1 | 2021 | 346 | 0.650 |
Why?
|
| Peptides | 20 | 2009 | 4354 | 0.650 |
Why?
|
| Interleukin-12 | 4 | 2014 | 577 | 0.640 |
Why?
|
| T-Box Domain Proteins | 7 | 2015 | 472 | 0.630 |
Why?
|
| Panniculitis | 1 | 2018 | 45 | 0.620 |
Why?
|
| Cell Lineage | 6 | 2021 | 2575 | 0.610 |
Why?
|
| Melanoma | 9 | 2023 | 5706 | 0.600 |
Why?
|
| Melanoma, Experimental | 7 | 2023 | 559 | 0.590 |
Why?
|
| Mice, Inbred BALB C | 33 | 2021 | 6231 | 0.580 |
Why?
|
| Interferon Regulatory Factor-1 | 2 | 2017 | 69 | 0.580 |
Why?
|
| Mice, Inbred NOD | 15 | 2015 | 1837 | 0.580 |
Why?
|
| Immunotherapy | 10 | 2023 | 4755 | 0.580 |
Why?
|
| Gastrointestinal Tract | 2 | 2021 | 840 | 0.570 |
Why?
|
| Respiratory Hypersensitivity | 3 | 2015 | 272 | 0.560 |
Why?
|
| Suppressor Factors, Immunologic | 15 | 1995 | 68 | 0.560 |
Why?
|
| Hypersensitivity | 5 | 2022 | 1172 | 0.560 |
Why?
|
| Flow Cytometry | 22 | 2023 | 5902 | 0.540 |
Why?
|
| Intestinal Mucosa | 5 | 2023 | 3044 | 0.520 |
Why?
|
| Receptors, Interleukin-2 | 8 | 2014 | 564 | 0.520 |
Why?
|
| Lymphoma, T-Cell | 1 | 2018 | 308 | 0.520 |
Why?
|
| Inflammasomes | 1 | 2021 | 540 | 0.520 |
Why?
|
| Transcription, Genetic | 9 | 2021 | 7608 | 0.510 |
Why?
|
| Humans | 178 | 2023 | 768166 | 0.510 |
Why?
|
| Listeriosis | 2 | 2014 | 147 | 0.510 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2016 | 133 | 0.510 |
Why?
|
| Cell Proliferation | 28 | 2021 | 10474 | 0.500 |
Why?
|
| Listeria monocytogenes | 2 | 2014 | 246 | 0.500 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2022 | 617 | 0.500 |
Why?
|
| Histocompatibility Antigens Class II | 14 | 2018 | 1441 | 0.500 |
Why?
|
| Immediate-Early Proteins | 3 | 2018 | 444 | 0.490 |
Why?
|
| Disease Models, Animal | 34 | 2023 | 18349 | 0.490 |
Why?
|
| Interleukin-6 | 11 | 2015 | 3228 | 0.490 |
Why?
|
| Hybridomas | 15 | 2006 | 444 | 0.490 |
Why?
|
| Transforming Growth Factor beta1 | 5 | 2023 | 638 | 0.490 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 7 | 2022 | 1105 | 0.480 |
Why?
|
| Clone Cells | 19 | 2021 | 1670 | 0.480 |
Why?
|
| Single-Cell Analysis | 9 | 2023 | 2540 | 0.470 |
Why?
|
| Macrophages | 12 | 2020 | 5799 | 0.470 |
Why?
|
| Sodium Chloride | 2 | 2015 | 584 | 0.470 |
Why?
|
| Clonal Anergy | 5 | 2015 | 169 | 0.460 |
Why?
|
| Metallothionein | 2 | 2016 | 62 | 0.460 |
Why?
|
| Benzeneacetamides | 1 | 2014 | 36 | 0.460 |
Why?
|
| Homeostasis | 8 | 2023 | 3348 | 0.460 |
Why?
|
| Antigens, Ly | 4 | 2010 | 297 | 0.450 |
Why?
|
| Oncogene Protein v-maf | 2 | 2010 | 5 | 0.450 |
Why?
|
| Immunization | 10 | 2016 | 1219 | 0.450 |
Why?
|
| Antigen Presentation | 9 | 2023 | 1251 | 0.450 |
Why?
|
| Immunoconjugates | 6 | 2002 | 975 | 0.450 |
Why?
|
| Immunity, Cellular | 12 | 2011 | 1561 | 0.440 |
Why?
|
| Transcriptional Activation | 4 | 2016 | 1750 | 0.440 |
Why?
|
| Mice, Inbred Strains | 21 | 2008 | 1765 | 0.440 |
Why?
|
| Tumor Microenvironment | 4 | 2023 | 3948 | 0.430 |
Why?
|
| Pneumonia | 4 | 2019 | 2163 | 0.430 |
Why?
|
| Macrophage Activation | 7 | 2015 | 557 | 0.430 |
Why?
|
| Receptors, Cell Surface | 5 | 2018 | 2819 | 0.430 |
Why?
|
| Interleukin-9 | 5 | 2012 | 62 | 0.420 |
Why?
|
| Digoxin | 1 | 2014 | 246 | 0.420 |
Why?
|
| Chromatin | 6 | 2021 | 2981 | 0.420 |
Why?
|
| Smad3 Protein | 2 | 2014 | 166 | 0.410 |
Why?
|
| Chromosome Mapping | 8 | 2004 | 4620 | 0.410 |
Why?
|
| Neoplasms, Experimental | 7 | 2019 | 1230 | 0.410 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2012 | 44 | 0.410 |
Why?
|
| Thymus Gland | 5 | 2010 | 1266 | 0.410 |
Why?
|
| T-Lymphocytes, Cytotoxic | 6 | 2015 | 1801 | 0.400 |
Why?
|
| Inflammation Mediators | 10 | 2020 | 1892 | 0.400 |
Why?
|
| Trans-Activators | 4 | 2015 | 2857 | 0.400 |
Why?
|
| Growth Inhibitors | 2 | 2011 | 375 | 0.390 |
Why?
|
| Protein Binding | 16 | 2018 | 9343 | 0.390 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 6 | 2018 | 354 | 0.390 |
Why?
|
| Gene Expression Profiling | 14 | 2020 | 9538 | 0.380 |
Why?
|
| Receptors, Aryl Hydrocarbon | 2 | 2012 | 221 | 0.380 |
Why?
|
| Epitopes, T-Lymphocyte | 10 | 2010 | 827 | 0.380 |
Why?
|
| Stem Cells | 2 | 2021 | 3537 | 0.370 |
Why?
|
| Polyamines | 2 | 2022 | 133 | 0.370 |
Why?
|
| Apoptosis | 15 | 2018 | 9523 | 0.370 |
Why?
|
| Psoriasis | 2 | 2016 | 926 | 0.370 |
Why?
|
| Down-Regulation | 5 | 2014 | 2937 | 0.370 |
Why?
|
| Genetic Predisposition to Disease | 21 | 2015 | 18065 | 0.360 |
Why?
|
| Glycoproteins | 12 | 2012 | 2202 | 0.360 |
Why?
|
| Receptors, Interleukin-17 | 2 | 2009 | 82 | 0.360 |
Why?
|
| Models, Immunological | 5 | 2019 | 518 | 0.350 |
Why?
|
| Cell Death | 3 | 2012 | 1679 | 0.350 |
Why?
|
| Receptors, Interleukin-6 | 2 | 2009 | 224 | 0.350 |
Why?
|
| Immunity | 4 | 2021 | 1003 | 0.350 |
Why?
|
| Spleen | 10 | 2021 | 2295 | 0.350 |
Why?
|
| Myeloid Cells | 3 | 2021 | 839 | 0.340 |
Why?
|
| Antigens, Neoplasm | 11 | 2019 | 1997 | 0.340 |
Why?
|
| Lymphocyte Subsets | 2 | 2021 | 313 | 0.340 |
Why?
|
| Nociceptors | 3 | 2019 | 460 | 0.330 |
Why?
|
| Antigens, Surface | 8 | 2011 | 1617 | 0.330 |
Why?
|
| Medical Oncology | 1 | 2021 | 2346 | 0.320 |
Why?
|
| Gene Expression | 14 | 2023 | 7598 | 0.320 |
Why?
|
| Lymph Nodes | 13 | 2023 | 3474 | 0.320 |
Why?
|
| Tretinoin | 2 | 2011 | 524 | 0.320 |
Why?
|
| Crosses, Genetic | 5 | 2012 | 752 | 0.320 |
Why?
|
| Cattle Diseases | 7 | 1985 | 50 | 0.320 |
Why?
|
| Cell Movement | 10 | 2021 | 5210 | 0.310 |
Why?
|
| Lectins, C-Type | 4 | 2019 | 594 | 0.310 |
Why?
|
| Arthritis | 1 | 2014 | 684 | 0.300 |
Why?
|
| Interferon-beta | 2 | 2013 | 349 | 0.300 |
Why?
|
| Cricetinae | 9 | 2011 | 2423 | 0.300 |
Why?
|
| Oligopeptides | 6 | 2014 | 1194 | 0.300 |
Why?
|
| Tumor Escape | 3 | 2017 | 372 | 0.300 |
Why?
|
| Antigens | 12 | 2016 | 1442 | 0.290 |
Why?
|
| Bacterial Infections | 2 | 2018 | 1397 | 0.290 |
Why?
|
| Nuclear Proteins | 2 | 2022 | 5804 | 0.290 |
Why?
|
| Adaptive Immunity | 2 | 2012 | 733 | 0.290 |
Why?
|
| Mice, 129 Strain | 4 | 2016 | 369 | 0.290 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 2094 | 0.290 |
Why?
|
| GATA3 Transcription Factor | 5 | 2017 | 163 | 0.280 |
Why?
|
| Virus Diseases | 2 | 2011 | 724 | 0.280 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 11 | 2015 | 4580 | 0.280 |
Why?
|
| Phenotype | 17 | 2022 | 16726 | 0.280 |
Why?
|
| Neuromyelitis Optica | 2 | 2013 | 266 | 0.280 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 17 | 2012 | 3814 | 0.280 |
Why?
|
| Islets of Langerhans | 2 | 2006 | 1351 | 0.280 |
Why?
|
| Killer Cells, Natural | 4 | 2014 | 2211 | 0.280 |
Why?
|
| Benzhydryl Compounds | 1 | 2014 | 944 | 0.280 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 1904 | 0.280 |
Why?
|
| Germinal Center | 3 | 2019 | 380 | 0.280 |
Why?
|
| Female | 98 | 2021 | 397192 | 0.270 |
Why?
|
| Thymoma | 2 | 1999 | 188 | 0.270 |
Why?
|
| Exons | 2 | 2011 | 2394 | 0.270 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 2013 | 1353 | 0.270 |
Why?
|
| Cross Reactions | 10 | 2004 | 828 | 0.260 |
Why?
|
| Immune System Diseases | 2 | 2006 | 253 | 0.260 |
Why?
|
| Immunologic Memory | 6 | 2019 | 1377 | 0.260 |
Why?
|
| Immunomodulation | 3 | 2020 | 549 | 0.260 |
Why?
|
| Epitopes | 18 | 2018 | 2528 | 0.260 |
Why?
|
| Mice, Mutant Strains | 5 | 2015 | 1754 | 0.250 |
Why?
|
| Immunophenotyping | 7 | 2016 | 1864 | 0.250 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 2021 | 892 | 0.250 |
Why?
|
| Interleukin-1beta | 5 | 2021 | 1027 | 0.240 |
Why?
|
| Promoter Regions, Genetic | 8 | 2018 | 5797 | 0.240 |
Why?
|
| Up-Regulation | 11 | 2019 | 4146 | 0.240 |
Why?
|
| Allergy and Immunology | 1 | 2006 | 175 | 0.240 |
Why?
|
| Lung | 4 | 2019 | 10099 | 0.240 |
Why?
|
| Epigenesis, Genetic | 5 | 2019 | 3833 | 0.230 |
Why?
|
| Phagocytosis | 4 | 2015 | 1530 | 0.230 |
Why?
|
| Phosphorylation | 7 | 2018 | 8317 | 0.230 |
Why?
|
| HEK293 Cells | 6 | 2018 | 4283 | 0.220 |
Why?
|
| Feedback, Physiological | 4 | 2023 | 482 | 0.220 |
Why?
|
| Cell Line | 21 | 2014 | 15597 | 0.220 |
Why?
|
| Sjogren's Syndrome | 4 | 2017 | 240 | 0.220 |
Why?
|
| Immune System | 3 | 2018 | 799 | 0.210 |
Why?
|
| Self Tolerance | 3 | 2015 | 122 | 0.210 |
Why?
|
| Th1-Th2 Balance | 2 | 2014 | 38 | 0.210 |
Why?
|
| DNA-Binding Proteins | 5 | 2015 | 9615 | 0.210 |
Why?
|
| Transfection | 12 | 2014 | 5755 | 0.210 |
Why?
|
| Protein Conformation | 6 | 2021 | 3956 | 0.210 |
Why?
|
| Periodicals as Topic | 2 | 2011 | 1465 | 0.210 |
Why?
|
| Laboratories | 1 | 2006 | 463 | 0.210 |
Why?
|
| Antibodies | 6 | 2013 | 2421 | 0.200 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2016 | 260 | 0.200 |
Why?
|
| Autophagy | 3 | 2021 | 1349 | 0.200 |
Why?
|
| Autocrine Communication | 1 | 2023 | 168 | 0.200 |
Why?
|
| Sodium Chloride, Dietary | 2 | 2015 | 301 | 0.190 |
Why?
|
| Cell Adhesion Molecules | 2 | 2021 | 1613 | 0.190 |
Why?
|
| Mucin-2 | 1 | 2021 | 50 | 0.190 |
Why?
|
| Immunodominant Epitopes | 3 | 2000 | 244 | 0.190 |
Why?
|
| Upstream Stimulatory Factors | 1 | 2020 | 18 | 0.180 |
Why?
|
| Reperfusion Injury | 4 | 2015 | 1039 | 0.180 |
Why?
|
| Optic Neuritis | 1 | 2003 | 175 | 0.180 |
Why?
|
| Disease Susceptibility | 5 | 2015 | 1793 | 0.180 |
Why?
|
| Cell Line, Tumor | 11 | 2021 | 17140 | 0.180 |
Why?
|
| Fatty Acids, Volatile | 1 | 2021 | 100 | 0.180 |
Why?
|
| Histocompatibility Antigens | 6 | 2010 | 479 | 0.180 |
Why?
|
| Blood Proteins | 2 | 2004 | 1191 | 0.180 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2002 | 327 | 0.180 |
Why?
|
| Mucins | 3 | 2022 | 570 | 0.170 |
Why?
|
| Quantitative Trait Loci | 1 | 2008 | 2131 | 0.170 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2001 | 1134 | 0.170 |
Why?
|
| Transplantation Tolerance | 3 | 2017 | 633 | 0.170 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2023 | 547 | 0.170 |
Why?
|
| Rats, Inbred Lew | 5 | 2010 | 1162 | 0.170 |
Why?
|
| RNA Splicing | 1 | 2005 | 905 | 0.170 |
Why?
|
| H-2 Antigens | 4 | 2000 | 359 | 0.170 |
Why?
|
| Cell Polarity | 4 | 2021 | 639 | 0.170 |
Why?
|
| Environmental Exposure | 1 | 2015 | 4543 | 0.170 |
Why?
|
| Arthritis, Rheumatoid | 5 | 2020 | 3781 | 0.170 |
Why?
|
| Microglia | 4 | 2023 | 1376 | 0.170 |
Why?
|
| Hypersensitivity, Delayed | 10 | 1995 | 491 | 0.170 |
Why?
|
| Interleukin-18 | 1 | 2021 | 251 | 0.170 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2023 | 627 | 0.160 |
Why?
|
| Lymphoid Tissue | 3 | 2011 | 445 | 0.160 |
Why?
|
| Glutamine | 1 | 2022 | 577 | 0.160 |
Why?
|
| Macrophages, Peritoneal | 2 | 2010 | 244 | 0.160 |
Why?
|
| Eye Neoplasms | 5 | 1987 | 306 | 0.160 |
Why?
|
| Interferon Type I | 1 | 2023 | 569 | 0.160 |
Why?
|
| Haplotypes | 2 | 2009 | 2722 | 0.160 |
Why?
|
| HLA-DR Antigens | 5 | 2017 | 609 | 0.160 |
Why?
|
| Atrioventricular Block | 2 | 2011 | 141 | 0.160 |
Why?
|
| Immunosuppressive Agents | 5 | 2011 | 4206 | 0.160 |
Why?
|
| Symbiosis | 1 | 2021 | 297 | 0.160 |
Why?
|
| Tumor Burden | 2 | 2023 | 1906 | 0.160 |
Why?
|
| Lymphocyte Count | 3 | 2017 | 794 | 0.160 |
Why?
|
| Receptors, Scavenger | 2 | 2015 | 123 | 0.160 |
Why?
|
| Herpesvirus 4, Human | 2 | 2022 | 1082 | 0.160 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2017 | 1143 | 0.150 |
Why?
|
| Rats | 16 | 2011 | 23760 | 0.150 |
Why?
|
| Goblet Cells | 1 | 2021 | 300 | 0.150 |
Why?
|
| Lactic Acid | 1 | 2023 | 1140 | 0.150 |
Why?
|
| Cell Survival | 7 | 2018 | 5777 | 0.150 |
Why?
|
| Apyrase | 2 | 2013 | 376 | 0.150 |
Why?
|
| Mice, Congenic | 3 | 2011 | 98 | 0.150 |
Why?
|
| Interleukin-23 Subunit p19 | 2 | 2010 | 23 | 0.150 |
Why?
|
| Crystallography, X-Ray | 2 | 2021 | 1951 | 0.150 |
Why?
|
| Protein Phosphatase 1 | 1 | 2018 | 135 | 0.140 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 1 | 2018 | 163 | 0.140 |
Why?
|
| DNA Primers | 6 | 2014 | 2828 | 0.140 |
Why?
|
| Cell Membrane | 2 | 2014 | 3655 | 0.140 |
Why?
|
| Neuroimmunomodulation | 1 | 2019 | 187 | 0.140 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2017 | 172 | 0.140 |
Why?
|
| Blotting, Western | 6 | 2015 | 5027 | 0.140 |
Why?
|
| Neutrophils | 4 | 2021 | 3786 | 0.140 |
Why?
|
| Receptor Cross-Talk | 2 | 2016 | 118 | 0.140 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2016 | 2062 | 0.140 |
Why?
|
| Sensory Receptor Cells | 2 | 2019 | 508 | 0.140 |
Why?
|
| Fasting | 1 | 2003 | 1610 | 0.130 |
Why?
|
| Superantigens | 1 | 1996 | 124 | 0.130 |
Why?
|
| Species Specificity | 5 | 2008 | 2415 | 0.130 |
Why?
|
| Phosphatidylserines | 2 | 2014 | 186 | 0.130 |
Why?
|
| Structure-Activity Relationship | 4 | 2021 | 3055 | 0.130 |
Why?
|
| Histocompatibility Antigens Class I | 3 | 2013 | 1361 | 0.130 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2023 | 820 | 0.130 |
Why?
|
| CHO Cells | 6 | 2002 | 1379 | 0.130 |
Why?
|
| Fatty Acids | 2 | 2021 | 1812 | 0.130 |
Why?
|
| Protein Structure, Tertiary | 5 | 2015 | 3772 | 0.130 |
Why?
|
| Astrocytes | 2 | 2023 | 1350 | 0.130 |
Why?
|
| Male | 41 | 2021 | 364719 | 0.130 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2014 | 304 | 0.130 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2015 | 30 | 0.130 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2016 | 434 | 0.130 |
Why?
|
| Rosette Formation | 4 | 1983 | 152 | 0.130 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2018 | 506 | 0.130 |
Why?
|
| Quantitative Trait, Heritable | 1 | 1999 | 540 | 0.130 |
Why?
|
| Epithelium | 2 | 2019 | 1607 | 0.130 |
Why?
|
| Genetic Vectors | 2 | 2018 | 3402 | 0.130 |
Why?
|
| Dose-Response Relationship, Immunologic | 6 | 2011 | 361 | 0.130 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2015 | 43 | 0.130 |
Why?
|
| Mice, Inbred DBA | 6 | 2014 | 624 | 0.130 |
Why?
|
| Cell Compartmentation | 2 | 2021 | 383 | 0.130 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2015 | 220 | 0.120 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2015 | 64 | 0.120 |
Why?
|
| Protein Multimerization | 3 | 2021 | 965 | 0.120 |
Why?
|
| Cloning, Molecular | 6 | 2004 | 4168 | 0.120 |
Why?
|
| Protein Isoforms | 3 | 2011 | 1715 | 0.120 |
Why?
|
| Chromosomes, Mammalian | 1 | 2015 | 148 | 0.120 |
Why?
|
| Enterotoxins | 1 | 1996 | 366 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2016 | 16045 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 3 | 2019 | 2040 | 0.120 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 806 | 0.120 |
Why?
|
| Caspases | 1 | 2018 | 882 | 0.120 |
Why?
|
| Lymphopoiesis | 1 | 2015 | 133 | 0.120 |
Why?
|
| Leptin | 1 | 2003 | 1599 | 0.120 |
Why?
|
| Germ Cells | 1 | 2018 | 644 | 0.120 |
Why?
|
| Genetic Markers | 2 | 2019 | 2603 | 0.120 |
Why?
|
| Mycobacterium tuberculosis | 4 | 2016 | 1930 | 0.120 |
Why?
|
| Androstenols | 1 | 2014 | 25 | 0.120 |
Why?
|
| Skin | 5 | 2016 | 4503 | 0.120 |
Why?
|
| Carcinoma, Squamous Cell | 9 | 1987 | 4058 | 0.120 |
Why?
|
| Horns | 4 | 1982 | 9 | 0.120 |
Why?
|
| Protein Transport | 2 | 2018 | 1951 | 0.120 |
Why?
|
| Regeneration | 1 | 2023 | 1524 | 0.120 |
Why?
|
| Receptors, Interleukin-12 | 1 | 2014 | 26 | 0.120 |
Why?
|
| Receptors, Prostaglandin E, EP2 Subtype | 1 | 2014 | 48 | 0.120 |
Why?
|
| Graft Rejection | 3 | 2022 | 4492 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2020 | 4352 | 0.110 |
Why?
|
| Thymus Neoplasms | 1 | 1997 | 274 | 0.110 |
Why?
|
| Lymphocytic Choriomeningitis | 2 | 2015 | 140 | 0.110 |
Why?
|
| Cell Transdifferentiation | 1 | 2015 | 186 | 0.110 |
Why?
|
| Airway Remodeling | 1 | 2015 | 133 | 0.110 |
Why?
|
| Cell Surface Extensions | 1 | 2014 | 66 | 0.110 |
Why?
|
| Atherosclerosis | 2 | 2022 | 3433 | 0.110 |
Why?
|
| Respiratory Mucosa | 1 | 2017 | 439 | 0.110 |
Why?
|
| Immunoglobulin Idiotypes | 5 | 1989 | 201 | 0.110 |
Why?
|
| Diabetic Nephropathies | 1 | 2021 | 973 | 0.110 |
Why?
|
| Oncolytic Viruses | 1 | 2018 | 344 | 0.110 |
Why?
|
| Receptors, Very Late Antigen | 1 | 1993 | 74 | 0.110 |
Why?
|
| Keratinocytes | 2 | 2016 | 876 | 0.110 |
Why?
|
| Myelin Sheath | 3 | 2013 | 652 | 0.110 |
Why?
|
| Cell Division | 6 | 2012 | 4473 | 0.110 |
Why?
|
| Glioblastoma | 3 | 2018 | 3464 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2013 | 514 | 0.110 |
Why?
|
| Maternal-Fetal Exchange | 3 | 2011 | 454 | 0.110 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2017 | 452 | 0.110 |
Why?
|
| Lymphocyte Cooperation | 1 | 2013 | 112 | 0.110 |
Why?
|
| Coculture Techniques | 7 | 2015 | 1340 | 0.110 |
Why?
|
| Gene Knock-In Techniques | 2 | 2012 | 422 | 0.110 |
Why?
|
| Heart Block | 2 | 2005 | 390 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2022 | 2909 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 6 | 2012 | 3740 | 0.100 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 20227 | 0.100 |
Why?
|
| GPI-Linked Proteins | 1 | 2014 | 472 | 0.100 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2012 | 66 | 0.100 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2016 | 588 | 0.100 |
Why?
|
| COS Cells | 3 | 2012 | 1135 | 0.100 |
Why?
|
| RNA, Messenger | 8 | 2016 | 12800 | 0.100 |
Why?
|
| Histones | 2 | 2021 | 2601 | 0.100 |
Why?
|
| Collagen | 3 | 2018 | 2643 | 0.100 |
Why?
|
| Interferon-alpha | 3 | 2017 | 910 | 0.100 |
Why?
|
| Polymorphism, Genetic | 4 | 2015 | 4249 | 0.100 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2015 | 542 | 0.100 |
Why?
|
| Immunity, Humoral | 2 | 2019 | 610 | 0.100 |
Why?
|
| Haptens | 5 | 1995 | 163 | 0.100 |
Why?
|
| Dopamine | 1 | 2019 | 1592 | 0.100 |
Why?
|
| Herpesvirus 1, Human | 1 | 2018 | 743 | 0.100 |
Why?
|
| Lymphopenia | 1 | 2014 | 300 | 0.100 |
Why?
|
| Base Sequence | 9 | 2014 | 12421 | 0.100 |
Why?
|
| Oncolytic Virotherapy | 1 | 2018 | 520 | 0.100 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2011 | 255 | 0.100 |
Why?
|
| Homeodomain Proteins | 4 | 2016 | 2429 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 4 | 2015 | 2065 | 0.100 |
Why?
|
| HLA-DR2 Antigen | 4 | 2005 | 45 | 0.100 |
Why?
|
| Immunoglobulins | 3 | 2005 | 855 | 0.100 |
Why?
|
| Interferon Regulatory Factors | 1 | 2013 | 271 | 0.100 |
Why?
|
| RNA Splice Sites | 1 | 2013 | 213 | 0.100 |
Why?
|
| Genetic Testing | 2 | 2023 | 3591 | 0.100 |
Why?
|
| Connexin 43 | 1 | 2012 | 202 | 0.100 |
Why?
|
| Models, Biological | 3 | 2021 | 9495 | 0.100 |
Why?
|
| Aortic Diseases | 1 | 2018 | 741 | 0.100 |
Why?
|
| RNA | 1 | 2021 | 2720 | 0.100 |
Why?
|
| Lupus Erythematosus, Systemic | 6 | 2013 | 2171 | 0.090 |
Why?
|
| Immunoassay | 2 | 2007 | 746 | 0.090 |
Why?
|
| Nitrophenols | 5 | 1995 | 169 | 0.090 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2011 | 58 | 0.090 |
Why?
|
| P-Selectin | 1 | 2014 | 598 | 0.090 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2012 | 75 | 0.090 |
Why?
|
| Influenza A virus | 2 | 2011 | 460 | 0.090 |
Why?
|
| Jurkat Cells | 3 | 2014 | 740 | 0.090 |
Why?
|
| Galectin 1 | 1 | 2012 | 128 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 2020 | 2167 | 0.090 |
Why?
|
| Genetic Linkage | 3 | 2003 | 2342 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 3800 | 0.090 |
Why?
|
| Genome | 2 | 2013 | 1754 | 0.090 |
Why?
|
| Ikaros Transcription Factor | 1 | 2012 | 233 | 0.090 |
Why?
|
| Caspase 3 | 1 | 2013 | 730 | 0.090 |
Why?
|
| Hepatocytes | 2 | 2014 | 1247 | 0.090 |
Why?
|
| Tuberculosis | 2 | 2016 | 2029 | 0.090 |
Why?
|
| Phosphotyrosine | 1 | 2011 | 458 | 0.090 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2013 | 587 | 0.090 |
Why?
|
| Retroviridae | 2 | 2012 | 846 | 0.090 |
Why?
|
| Systems Biology | 1 | 2014 | 482 | 0.090 |
Why?
|
| Statistics, Nonparametric | 2 | 2014 | 2862 | 0.090 |
Why?
|
| STAT4 Transcription Factor | 1 | 2010 | 94 | 0.090 |
Why?
|
| Germ-Line Mutation | 1 | 2018 | 1885 | 0.090 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2010 | 158 | 0.090 |
Why?
|
| Citric Acid Cycle | 2 | 2021 | 234 | 0.090 |
Why?
|
| HIV Infections | 2 | 2014 | 17569 | 0.090 |
Why?
|
| Melatonin | 1 | 2015 | 670 | 0.090 |
Why?
|
| Aorta | 1 | 2018 | 2045 | 0.080 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2012 | 423 | 0.080 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 1110 | 0.080 |
Why?
|
| Influenza Vaccines | 1 | 2017 | 781 | 0.080 |
Why?
|
| Lymphocytic choriomeningitis virus | 3 | 2018 | 176 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2017 | 2732 | 0.080 |
Why?
|
| Transplantation | 1 | 2011 | 221 | 0.080 |
Why?
|
| Brain | 6 | 2014 | 27360 | 0.080 |
Why?
|
| Mice, Inbred MRL lpr | 3 | 2013 | 158 | 0.080 |
Why?
|
| Transduction, Genetic | 1 | 2012 | 899 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2019 | 3671 | 0.080 |
Why?
|
| Interleukin-13 | 3 | 2019 | 390 | 0.080 |
Why?
|
| Models, Molecular | 4 | 2014 | 5403 | 0.080 |
Why?
|
| Chronic Disease | 3 | 2014 | 9384 | 0.080 |
Why?
|
| Eosinophils | 1 | 2014 | 952 | 0.080 |
Why?
|
| Interleukin-1 | 1 | 2013 | 1252 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2009 | 190 | 0.080 |
Why?
|
| Antibodies, Blocking | 4 | 2014 | 250 | 0.080 |
Why?
|
| Binding Sites | 2 | 2016 | 6020 | 0.080 |
Why?
|
| Cancer Vaccines | 2 | 2013 | 1041 | 0.080 |
Why?
|
| Cricetulus | 1 | 2011 | 812 | 0.080 |
Why?
|
| Immunity, Mucosal | 2 | 2018 | 498 | 0.080 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 2 | 2020 | 174 | 0.080 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 801 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2018 | 2748 | 0.080 |
Why?
|
| Receptors, Chemokine | 2 | 2015 | 652 | 0.080 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2010 | 289 | 0.080 |
Why?
|
| RNA, Small Interfering | 4 | 2021 | 3428 | 0.080 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2008 | 67 | 0.080 |
Why?
|
| Chemokines | 2 | 2021 | 963 | 0.080 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2013 | 582 | 0.080 |
Why?
|
| Antibodies, Antinuclear | 1 | 2010 | 342 | 0.080 |
Why?
|
| Cell Separation | 2 | 2013 | 1728 | 0.080 |
Why?
|
| Asthma | 4 | 2019 | 6291 | 0.080 |
Why?
|
| STAT6 Transcription Factor | 1 | 2008 | 196 | 0.080 |
Why?
|
| Plant Lectins | 1 | 1988 | 103 | 0.080 |
Why?
|
| Models, Animal | 1 | 2015 | 2120 | 0.080 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2010 | 355 | 0.080 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 2 | 2011 | 69 | 0.080 |
Why?
|
| Mutagenesis | 1 | 2012 | 1228 | 0.080 |
Why?
|
| Neoplasm Proteins | 4 | 2015 | 3603 | 0.070 |
Why?
|
| Docosahexaenoic Acids | 1 | 2014 | 914 | 0.070 |
Why?
|
| Immunoproteins | 1 | 2007 | 3 | 0.070 |
Why?
|
| Lupus Erythematosus, Cutaneous | 1 | 2009 | 75 | 0.070 |
Why?
|
| Antibody Specificity | 5 | 2011 | 1065 | 0.070 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 2 | 2021 | 168 | 0.070 |
Why?
|
| Vaccination | 6 | 2017 | 3437 | 0.070 |
Why?
|
| Clonal Deletion | 2 | 2019 | 75 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2012 | 2474 | 0.070 |
Why?
|
| Fas Ligand Protein | 2 | 1999 | 216 | 0.070 |
Why?
|
| Isoantigens | 2 | 2007 | 562 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 3 | 2001 | 6124 | 0.070 |
Why?
|
| Encephalomyelitis | 1 | 2007 | 37 | 0.070 |
Why?
|
| Adenosine | 2 | 2014 | 820 | 0.070 |
Why?
|
| Spinal Cord | 2 | 2006 | 1811 | 0.070 |
Why?
|
| HIV | 1 | 2014 | 1597 | 0.070 |
Why?
|
| Lysine | 2 | 2021 | 1000 | 0.070 |
Why?
|
| Lysosomes | 1 | 2012 | 938 | 0.070 |
Why?
|
| Tissue Adhesions | 1 | 2008 | 222 | 0.070 |
Why?
|
| DNA, Complementary | 2 | 2014 | 1989 | 0.070 |
Why?
|
| Interleukin-5 | 2 | 2019 | 267 | 0.070 |
Why?
|
| Dermatitis | 1 | 2009 | 203 | 0.070 |
Why?
|
| Skin Transplantation | 1 | 2012 | 1096 | 0.070 |
Why?
|
| Receptors, CCR6 | 2 | 2020 | 73 | 0.070 |
Why?
|
| Enzyme Inhibitors | 2 | 2021 | 3728 | 0.070 |
Why?
|
| Cholesterol | 1 | 2015 | 2914 | 0.070 |
Why?
|
| Cattle | 10 | 1987 | 3819 | 0.070 |
Why?
|
| Encephalomyelitis, Acute Disseminated | 1 | 2007 | 68 | 0.070 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2021 | 386 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 2 | 2015 | 2830 | 0.070 |
Why?
|
| Animals, Newborn | 3 | 2015 | 2678 | 0.070 |
Why?
|
| Lupus Nephritis | 1 | 2010 | 327 | 0.070 |
Why?
|
| Immunoglobulin G | 4 | 2019 | 4568 | 0.070 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 1551 | 0.070 |
Why?
|
| Immunohistochemistry | 5 | 2018 | 11095 | 0.060 |
Why?
|
| Receptors, CCR7 | 1 | 2006 | 105 | 0.060 |
Why?
|
| I-kappa B Kinase | 1 | 2007 | 250 | 0.060 |
Why?
|
| Liver Diseases | 1 | 2014 | 1305 | 0.060 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2014 | 1276 | 0.060 |
Why?
|
| 5'-Nucleotidase | 1 | 2007 | 164 | 0.060 |
Why?
|
| Antibodies, Viral | 1 | 2017 | 3216 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2006 | 102 | 0.060 |
Why?
|
| Gene Order | 2 | 2018 | 166 | 0.060 |
Why?
|
| Arthritis, Experimental | 1 | 2008 | 293 | 0.060 |
Why?
|
| Graft Survival | 3 | 2015 | 3887 | 0.060 |
Why?
|
| Cell Communication | 2 | 2012 | 1660 | 0.060 |
Why?
|
| Recombination, Genetic | 1 | 2010 | 1525 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2019 | 4428 | 0.060 |
Why?
|
| Monocytes | 2 | 2021 | 2605 | 0.060 |
Why?
|
| Intestine, Small | 1 | 2011 | 1217 | 0.060 |
Why?
|
| Administration, Intranasal | 2 | 2023 | 485 | 0.060 |
Why?
|
| Recombinant Proteins | 6 | 2007 | 6514 | 0.060 |
Why?
|
| Animals, Congenic | 1 | 2004 | 27 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 1805 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 3 | 2014 | 1606 | 0.060 |
Why?
|
| Staining and Labeling | 2 | 2014 | 1081 | 0.060 |
Why?
|
| Receptors, CXCR3 | 2 | 2020 | 240 | 0.060 |
Why?
|
| Vertebrates | 1 | 2006 | 227 | 0.060 |
Why?
|
| Freund's Adjuvant | 2 | 2015 | 144 | 0.060 |
Why?
|
| STAT5 Transcription Factor | 2 | 2019 | 268 | 0.060 |
Why?
|
| Synovial Membrane | 1 | 2007 | 536 | 0.060 |
Why?
|
| HeLa Cells | 4 | 2014 | 3074 | 0.060 |
Why?
|
| Cystic Fibrosis | 1 | 2014 | 1294 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 2709 | 0.060 |
Why?
|
| Fibrosarcoma | 1 | 1986 | 313 | 0.060 |
Why?
|
| Calcium | 4 | 2011 | 5792 | 0.060 |
Why?
|
| Amino Acid Motifs | 2 | 2007 | 930 | 0.060 |
Why?
|
| Cytoplasm | 2 | 2014 | 1505 | 0.060 |
Why?
|
| Kidney | 3 | 2015 | 7064 | 0.060 |
Why?
|
| Radiation Chimera | 2 | 2015 | 216 | 0.060 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2006 | 648 | 0.050 |
Why?
|
| Colorectal Neoplasms | 2 | 2021 | 6974 | 0.050 |
Why?
|
| Paralysis | 2 | 2005 | 250 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 8054 | 0.050 |
Why?
|
| Theilovirus | 1 | 2003 | 11 | 0.050 |
Why?
|
| Graft vs Host Disease | 2 | 2015 | 3049 | 0.050 |
Why?
|
| Lactase | 1 | 2023 | 72 | 0.050 |
Why?
|
| Cell Line, Transformed | 2 | 2002 | 866 | 0.050 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily D | 1 | 2002 | 30 | 0.050 |
Why?
|
| Ovalbumin | 4 | 2015 | 677 | 0.050 |
Why?
|
| Blotting, Northern | 3 | 1995 | 1550 | 0.050 |
Why?
|
| Endocytosis | 2 | 2021 | 956 | 0.050 |
Why?
|
| Receptors, Natural Killer Cell | 1 | 2002 | 56 | 0.050 |
Why?
|
| Immunization, Passive | 3 | 2001 | 619 | 0.050 |
Why?
|
| Carrier Proteins | 4 | 2015 | 4937 | 0.050 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily C | 1 | 2002 | 38 | 0.050 |
Why?
|
| Food Deprivation | 1 | 2003 | 114 | 0.050 |
Why?
|
| Optic Nerve | 1 | 2006 | 571 | 0.050 |
Why?
|
| Mice, Inbred C3H | 3 | 1996 | 915 | 0.050 |
Why?
|
| Baculoviridae | 1 | 2003 | 115 | 0.050 |
Why?
|
| Genomics | 1 | 2019 | 5926 | 0.050 |
Why?
|
| Mice, Inbred CBA | 3 | 1996 | 439 | 0.050 |
Why?
|
| Demyelinating Diseases | 2 | 1996 | 358 | 0.050 |
Why?
|
| Chagas Disease | 1 | 2004 | 166 | 0.050 |
Why?
|
| Acute Kidney Injury | 1 | 2015 | 1942 | 0.050 |
Why?
|
| Neuraminidase | 1 | 2003 | 195 | 0.050 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2023 | 174 | 0.050 |
Why?
|
| Liver Transplantation | 1 | 2014 | 2401 | 0.050 |
Why?
|
| Multigene Family | 2 | 2002 | 1081 | 0.050 |
Why?
|
| Trypanosoma cruzi | 1 | 2004 | 204 | 0.050 |
Why?
|
| Leukopoiesis | 1 | 2002 | 54 | 0.050 |
Why?
|
| Brain Injuries | 1 | 2014 | 2057 | 0.050 |
Why?
|
| Vaccines, DNA | 1 | 2003 | 279 | 0.050 |
Why?
|
| Peyer's Patches | 2 | 2019 | 120 | 0.050 |
Why?
|
| Macaca mulatta | 1 | 2008 | 2363 | 0.050 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2001 | 75 | 0.050 |
Why?
|
| Phytohemagglutinins | 1 | 1981 | 165 | 0.050 |
Why?
|
| Eflornithine | 1 | 2021 | 31 | 0.050 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 2 | 1992 | 94 | 0.050 |
Why?
|
| Protein Array Analysis | 1 | 2003 | 399 | 0.050 |
Why?
|
| Putrescine | 1 | 2021 | 42 | 0.050 |
Why?
|
| Research Personnel | 1 | 2006 | 589 | 0.050 |
Why?
|
| Receptors, Complement 3b | 1 | 2001 | 136 | 0.050 |
Why?
|
| Aerobiosis | 1 | 2021 | 100 | 0.050 |
Why?
|
| Ornithine Decarboxylase | 1 | 2021 | 63 | 0.050 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2001 | 85 | 0.050 |
Why?
|
| Aging | 1 | 2020 | 8744 | 0.050 |
Why?
|
| rho-Associated Kinases | 1 | 2023 | 290 | 0.050 |
Why?
|
| Fluorometry | 1 | 2021 | 99 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2002 | 474 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2002 | 1683 | 0.050 |
Why?
|
| Zinc | 1 | 2005 | 677 | 0.050 |
Why?
|
| Receptors, Complement | 1 | 2001 | 254 | 0.050 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2001 | 141 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 478 | 0.050 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 440 | 0.050 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2001 | 283 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2013 | 2496 | 0.050 |
Why?
|
| Antigens, CD1d | 1 | 2001 | 225 | 0.040 |
Why?
|
| Palmitic Acid | 1 | 2021 | 149 | 0.040 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2001 | 301 | 0.040 |
Why?
|
| Fibrosis | 2 | 2021 | 2080 | 0.040 |
Why?
|
| Serum Albumin, Bovine | 1 | 2021 | 320 | 0.040 |
Why?
|
| Hyperplasia | 2 | 2016 | 1151 | 0.040 |
Why?
|
| Immune Sera | 1 | 2000 | 605 | 0.040 |
Why?
|
| Protein Phosphatase 2 | 1 | 2002 | 231 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2008 | 1901 | 0.040 |
Why?
|
| Acetyltransferases | 1 | 2021 | 231 | 0.040 |
Why?
|
| Kinetics | 3 | 2005 | 6329 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2009 | 1596 | 0.040 |
Why?
|
| Immunotherapy, Adoptive | 3 | 2012 | 1512 | 0.040 |
Why?
|
| RNA Interference | 2 | 2021 | 2832 | 0.040 |
Why?
|
| Optic Nerve Injuries | 1 | 2001 | 150 | 0.040 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2021 | 170 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 2 | 2000 | 998 | 0.040 |
Why?
|
| Mutation | 4 | 2021 | 30238 | 0.040 |
Why?
|
| Antibodies, Neoplasm | 3 | 1985 | 283 | 0.040 |
Why?
|
| Osteoarthritis | 1 | 2007 | 1072 | 0.040 |
Why?
|
| Germ-Free Life | 1 | 2000 | 187 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2018 | 1247 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2018 | 1367 | 0.040 |
Why?
|
| Epithelial Cells | 3 | 2018 | 3703 | 0.040 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2019 | 101 | 0.040 |
Why?
|
| Fetal Diseases | 1 | 2005 | 916 | 0.040 |
Why?
|
| Probiotics | 1 | 2023 | 387 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2002 | 841 | 0.040 |
Why?
|
| Antirheumatic Agents | 2 | 2020 | 1381 | 0.040 |
Why?
|
| Hematopoiesis | 2 | 2020 | 2059 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2018 | 2675 | 0.040 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2019 | 168 | 0.040 |
Why?
|
| Pancreas | 1 | 2006 | 1700 | 0.040 |
Why?
|
| Pyroglyphidae | 1 | 2019 | 92 | 0.040 |
Why?
|
| Adult | 10 | 2022 | 223646 | 0.040 |
Why?
|
| Hepatitis C | 1 | 2009 | 1595 | 0.040 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2004 | 558 | 0.040 |
Why?
|
| Antigens, CD1 | 1 | 2001 | 434 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2014 | 3463 | 0.040 |
Why?
|
| Genes, Reporter | 2 | 2015 | 1524 | 0.040 |
Why?
|
| Genes, Lethal | 2 | 2011 | 224 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 948 | 0.040 |
Why?
|
| Receptors, Cytokine | 2 | 2013 | 258 | 0.040 |
Why?
|
| Salmonella enterica | 1 | 2018 | 75 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2020 | 309 | 0.040 |
Why?
|
| Sulfones | 1 | 2021 | 448 | 0.040 |
Why?
|
| Cyclophosphamide | 1 | 2004 | 2227 | 0.040 |
Why?
|
| Salmonella Infections | 1 | 2019 | 173 | 0.040 |
Why?
|
| Proteolipids | 2 | 1995 | 112 | 0.040 |
Why?
|
| Biological Transport | 1 | 2003 | 2085 | 0.040 |
Why?
|
| DNA Mismatch Repair | 1 | 2021 | 431 | 0.040 |
Why?
|
| Mice, Inbred AKR | 2 | 1996 | 104 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 2 | 2018 | 1469 | 0.040 |
Why?
|
| Phenylacetates | 4 | 1995 | 112 | 0.040 |
Why?
|
| Immunoglobulin D | 1 | 2017 | 55 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 1245 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 8647 | 0.040 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 2018 | 131 | 0.040 |
Why?
|
| Amino Acids | 1 | 2004 | 1716 | 0.040 |
Why?
|
| Computational Biology | 2 | 2019 | 3568 | 0.040 |
Why?
|
| Receptors, IgG | 1 | 2000 | 564 | 0.040 |
Why?
|
| Salmonella typhimurium | 1 | 2019 | 348 | 0.040 |
Why?
|
| Weight Loss | 2 | 2001 | 2721 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 1 | 2023 | 942 | 0.030 |
Why?
|
| Glycolysis | 1 | 2021 | 837 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2007 | 4176 | 0.030 |
Why?
|
| Leukocyte Adherence Inhibition Test | 2 | 1987 | 6 | 0.030 |
Why?
|
| Ganglia, Spinal | 1 | 2019 | 529 | 0.030 |
Why?
|
| Sympathetic Nervous System | 1 | 2019 | 521 | 0.030 |
Why?
|
| Erythrocytes | 2 | 1983 | 2418 | 0.030 |
Why?
|
| Integrins | 1 | 2001 | 842 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 9118 | 0.030 |
Why?
|
| TRPV Cation Channels | 1 | 2018 | 244 | 0.030 |
Why?
|
| Sarcoma, Experimental | 2 | 1987 | 117 | 0.030 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2017 | 199 | 0.030 |
Why?
|
| Binding, Competitive | 3 | 2000 | 1142 | 0.030 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2021 | 845 | 0.030 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2017 | 169 | 0.030 |
Why?
|
| Mice, Inbred A | 1 | 1996 | 245 | 0.030 |
Why?
|
| Lymphokines | 3 | 1990 | 924 | 0.030 |
Why?
|
| Staphylococcal Infections | 2 | 2018 | 1398 | 0.030 |
Why?
|
| DNA | 4 | 2013 | 7214 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2021 | 1336 | 0.030 |
Why?
|
| Disease Progression | 3 | 2012 | 13671 | 0.030 |
Why?
|
| Actins | 2 | 2014 | 2064 | 0.030 |
Why?
|
| p-Azobenzenearsonate | 1 | 1995 | 41 | 0.030 |
Why?
|
| Transplantation Immunology | 1 | 1998 | 537 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2006 | 2981 | 0.030 |
Why?
|
| Polymers | 1 | 2003 | 1630 | 0.030 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 2 | 2007 | 306 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 4 | 2007 | 6082 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2023 | 2149 | 0.030 |
Why?
|
| Benzamides | 1 | 2021 | 1379 | 0.030 |
Why?
|
| Sirolimus | 2 | 2016 | 1540 | 0.030 |
Why?
|
| Vagus Nerve | 1 | 2018 | 459 | 0.030 |
Why?
|
| Drug Design | 2 | 2014 | 1046 | 0.030 |
Why?
|
| LLC-PK1 Cells | 1 | 2015 | 125 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2018 | 493 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 2227 | 0.030 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2011 | 3626 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2005 | 2650 | 0.030 |
Why?
|
| Interleukin-12 Receptor beta 1 Subunit | 1 | 2014 | 3 | 0.030 |
Why?
|
| Raffinose | 1 | 2014 | 57 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2021 | 2004 | 0.030 |
Why?
|
| Oligodendroglia | 2 | 2011 | 540 | 0.030 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2015 | 179 | 0.030 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2021 | 1124 | 0.030 |
Why?
|
| Endothelial Cells | 2 | 2021 | 3589 | 0.030 |
Why?
|
| NF-kappa B | 2 | 2015 | 2493 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2002 | 1767 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2015 | 2885 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2018 | 572 | 0.030 |
Why?
|
| Capsaicin | 1 | 2015 | 235 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 6316 | 0.030 |
Why?
|
| Antigens, CD19 | 1 | 2017 | 446 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 2014 | 363 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2015 | 287 | 0.030 |
Why?
|
| Organ Preservation Solutions | 1 | 2014 | 104 | 0.030 |
Why?
|
| Hemolysin Proteins | 1 | 2014 | 113 | 0.030 |
Why?
|
| Interferon Regulatory Factor-2 | 1 | 2013 | 22 | 0.030 |
Why?
|
| Interleukin-3 | 1 | 1995 | 425 | 0.030 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2014 | 510 | 0.030 |
Why?
|
| Administration, Oral | 5 | 2005 | 4030 | 0.030 |
Why?
|
| Conserved Sequence | 2 | 2013 | 1162 | 0.030 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1997 | 528 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2002 | 8128 | 0.030 |
Why?
|
| T-Cell Antigen Receptor Specificity | 1 | 2013 | 89 | 0.030 |
Why?
|
| Genome-Wide Association Study | 2 | 2014 | 12795 | 0.030 |
Why?
|
| Histological Techniques | 1 | 2014 | 194 | 0.030 |
Why?
|
| Epidermis | 1 | 2016 | 539 | 0.030 |
Why?
|
| Type C Phospholipases | 1 | 2014 | 287 | 0.030 |
Why?
|
| Vacuoles | 1 | 2014 | 224 | 0.030 |
Why?
|
| Spinal Cord Injuries | 1 | 2001 | 928 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2002 | 2433 | 0.030 |
Why?
|
| Lipopolysaccharides | 2 | 2014 | 2219 | 0.030 |
Why?
|
| Nanowires | 1 | 2013 | 31 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2005 | 505 | 0.030 |
Why?
|
| Hydroxychloroquine | 1 | 2017 | 426 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2019 | 864 | 0.030 |
Why?
|
| Allopurinol | 1 | 2014 | 202 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2015 | 1854 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2019 | 1506 | 0.030 |
Why?
|
| DNA Damage | 2 | 2021 | 2469 | 0.030 |
Why?
|
| Phagosomes | 1 | 2014 | 198 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2010 | 3623 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2015 | 507 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2012 | 5863 | 0.030 |
Why?
|
| Nephritis | 1 | 2013 | 147 | 0.030 |
Why?
|
| Computer-Aided Design | 1 | 2014 | 294 | 0.030 |
Why?
|
| Endothelium, Lymphatic | 1 | 2012 | 63 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2012 | 91 | 0.030 |
Why?
|
| Silicon | 1 | 2013 | 143 | 0.030 |
Why?
|
| Myosin Light Chains | 1 | 2012 | 122 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2012 | 294 | 0.030 |
Why?
|
| Organoids | 1 | 2018 | 743 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2002 | 2892 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2013 | 705 | 0.020 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2012 | 107 | 0.020 |
Why?
|
| Protein Folding | 2 | 2007 | 871 | 0.020 |
Why?
|
| Glutathione | 1 | 2014 | 589 | 0.020 |
Why?
|
| Protein Structure, Secondary | 2 | 2005 | 1216 | 0.020 |
Why?
|
| Response Elements | 1 | 2013 | 307 | 0.020 |
Why?
|
| Lidocaine | 1 | 2015 | 546 | 0.020 |
Why?
|
| Recurrence | 3 | 2015 | 8509 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2012 | 463 | 0.020 |
Why?
|
| Case-Control Studies | 3 | 2017 | 22291 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2011 | 114 | 0.020 |
Why?
|
| Acute-Phase Reaction | 1 | 2011 | 91 | 0.020 |
Why?
|
| Neurons | 2 | 2014 | 9514 | 0.020 |
Why?
|
| Stroke | 1 | 2014 | 9755 | 0.020 |
Why?
|
| Oligonucleotides | 2 | 1991 | 563 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2011 | 6229 | 0.020 |
Why?
|
| Chemokine CCL20 | 1 | 2011 | 64 | 0.020 |
Why?
|
| Cyclooxygenase 1 | 1 | 2011 | 98 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2012 | 290 | 0.020 |
Why?
|
| Leukocytes | 1 | 1999 | 2035 | 0.020 |
Why?
|
| Immunodiffusion | 2 | 1982 | 141 | 0.020 |
Why?
|
| Alleles | 2 | 2015 | 6894 | 0.020 |
Why?
|
| Molecular Weight | 2 | 1990 | 2173 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2014 | 597 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2012 | 178 | 0.020 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2012 | 235 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2014 | 659 | 0.020 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2012 | 246 | 0.020 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 1990 | 32 | 0.020 |
Why?
|
| Organ Preservation | 1 | 2014 | 393 | 0.020 |
Why?
|
| Luciferases | 1 | 2012 | 713 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2015 | 966 | 0.020 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2011 | 128 | 0.020 |
Why?
|
| Receptors, Leukocyte-Adhesion | 1 | 1990 | 53 | 0.020 |
Why?
|
| Age Factors | 2 | 2019 | 18412 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2021 | 3780 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2015 | 832 | 0.020 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2014 | 486 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1996 | 2596 | 0.020 |
Why?
|
| Carotid Stenosis | 1 | 2018 | 859 | 0.020 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2012 | 112 | 0.020 |
Why?
|
| Dimerization | 1 | 2012 | 887 | 0.020 |
Why?
|
| Cell Count | 1 | 2014 | 1832 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2012 | 605 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2014 | 797 | 0.020 |
Why?
|
| Liver | 2 | 2011 | 7577 | 0.020 |
Why?
|
| Chemotactic Factors | 1 | 1990 | 197 | 0.020 |
Why?
|
| Virus Replication | 1 | 2018 | 2458 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2018 | 1430 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2018 | 65371 | 0.020 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2012 | 287 | 0.020 |
Why?
|
| Middle Aged | 9 | 2019 | 223492 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2011 | 321 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2015 | 1656 | 0.020 |
Why?
|
| Caspase 1 | 1 | 2010 | 227 | 0.020 |
Why?
|
| Nitrogenous Group Transferases | 1 | 2009 | 4 | 0.020 |
Why?
|
| Myocytes, Cardiac | 2 | 2011 | 1681 | 0.020 |
Why?
|
| Proteins | 2 | 2001 | 6009 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3611 | 0.020 |
Why?
|
| Prostatic Secretory Proteins | 1 | 1989 | 24 | 0.020 |
Why?
|
| Seasons | 1 | 2015 | 1524 | 0.020 |
Why?
|
| Light | 1 | 2015 | 1355 | 0.020 |
Why?
|
| Time Factors | 4 | 2015 | 40218 | 0.020 |
Why?
|
| NFATC Transcription Factors | 1 | 2011 | 393 | 0.020 |
Why?
|
| Podocytes | 1 | 2013 | 403 | 0.020 |
Why?
|
| Cerebral Infarction | 1 | 2014 | 969 | 0.020 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 1990 | 381 | 0.020 |
Why?
|
| Platelet Activation | 1 | 2012 | 644 | 0.020 |
Why?
|
| Trinitrobenzenes | 1 | 1988 | 45 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2011 | 598 | 0.020 |
Why?
|
| Epigenomics | 1 | 2014 | 960 | 0.020 |
Why?
|
| Cisplatin | 1 | 2015 | 1660 | 0.020 |
Why?
|
| Peritoneum | 1 | 2010 | 230 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2011 | 539 | 0.020 |
Why?
|
| Hepatitis A | 1 | 2009 | 126 | 0.020 |
Why?
|
| Interleukin-16 | 1 | 2008 | 34 | 0.020 |
Why?
|
| Receptors, OX40 | 1 | 2008 | 46 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 10760 | 0.020 |
Why?
|
| Perforin | 1 | 2008 | 167 | 0.020 |
Why?
|
| Bacterial Toxins | 1 | 2014 | 922 | 0.020 |
Why?
|
| Physical Chromosome Mapping | 1 | 2008 | 183 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 1494 | 0.020 |
Why?
|
| Anesthetics, Local | 1 | 2015 | 1005 | 0.020 |
Why?
|
| Genes, MHC Class I | 1 | 1988 | 235 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 2 | 1989 | 355 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2008 | 247 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 2014 | 0.020 |
Why?
|
| Pregnancy | 4 | 2012 | 30256 | 0.020 |
Why?
|
| Amino Acid Substitution | 2 | 2004 | 1743 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2014 | 1505 | 0.020 |
Why?
|
| Molecular Imaging | 1 | 2014 | 826 | 0.020 |
Why?
|
| Granzymes | 1 | 2008 | 277 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2013 | 3590 | 0.020 |
Why?
|
| Sex Factors | 1 | 2001 | 10632 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 1988 | 513 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 4912 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2008 | 432 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 1676 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 1972 | 0.020 |
Why?
|
| Genotype | 1 | 2001 | 13045 | 0.020 |
Why?
|
| Lectins | 1 | 1988 | 490 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 2010 | 995 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2015 | 2629 | 0.020 |
Why?
|
| Glycosylation | 3 | 1997 | 1100 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2013 | 1542 | 0.020 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 899 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2008 | 15832 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2015 | 2011 | 0.020 |
Why?
|
| Synovial Fluid | 1 | 2007 | 393 | 0.020 |
Why?
|
| Interferons | 1 | 2009 | 720 | 0.020 |
Why?
|
| Immunosorbent Techniques | 1 | 1985 | 174 | 0.020 |
Why?
|
| Tissue Extracts | 1 | 1985 | 139 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2005 | 337 | 0.020 |
Why?
|
| Leucine Zippers | 1 | 2005 | 116 | 0.020 |
Why?
|
| Bystander Effect | 1 | 2005 | 89 | 0.010 |
Why?
|
| Mast Cells | 1 | 2012 | 1406 | 0.010 |
Why?
|
| Swine | 1 | 2015 | 5995 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1997 | 3573 | 0.010 |
Why?
|
| Sequence Analysis, Protein | 1 | 2006 | 264 | 0.010 |
Why?
|
| Aged | 6 | 2019 | 171504 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2015 | 2982 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1985 | 530 | 0.010 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2007 | 296 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2007 | 777 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2012 | 2914 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2013 | 2146 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 7477 | 0.010 |
Why?
|
| Antilymphocyte Serum | 1 | 1986 | 492 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 1989 | 1083 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2005 | 646 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2007 | 582 | 0.010 |
Why?
|
| Biophysics | 1 | 2005 | 379 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2009 | 1103 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2015 | 2541 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 4833 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 1377 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2014 | 3139 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2005 | 694 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2005 | 577 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2008 | 2923 | 0.010 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2008 | 748 | 0.010 |
Why?
|
| Lipids | 1 | 2013 | 3343 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2007 | 2627 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 15948 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2011 | 2451 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 2003 | 365 | 0.010 |
Why?
|
| Sweden | 1 | 2005 | 1382 | 0.010 |
Why?
|
| Blood Platelets | 1 | 2012 | 2479 | 0.010 |
Why?
|
| Nerve Crush | 1 | 2001 | 77 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2008 | 3623 | 0.010 |
Why?
|
| Acute Disease | 1 | 2012 | 7243 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 911 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 2004 | 540 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2004 | 1966 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 2457 | 0.010 |
Why?
|
| Integrin alpha4beta1 | 1 | 2001 | 119 | 0.010 |
Why?
|
| Transgenes | 1 | 2004 | 1016 | 0.010 |
Why?
|
| Algorithms | 1 | 2021 | 14164 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2014 | 3301 | 0.010 |
Why?
|
| Thymectomy | 1 | 2001 | 200 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2001 | 387 | 0.010 |
Why?
|
| Insulin | 1 | 2014 | 6607 | 0.010 |
Why?
|
| Sheep | 1 | 1982 | 1451 | 0.010 |
Why?
|
| Protein Interaction Mapping | 1 | 2003 | 622 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2005 | 1027 | 0.010 |
Why?
|
| Point Mutation | 1 | 2005 | 1596 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 2001 | 1310 | 0.010 |
Why?
|
| Lymphotoxin-alpha | 1 | 1999 | 94 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1986 | 3096 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2019 | 26422 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2008 | 2885 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 1999 | 340 | 0.010 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 2298 | 0.010 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2007 | 928 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2011 | 2538 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 1999 | 411 | 0.010 |
Why?
|
| Hindlimb | 1 | 2001 | 516 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 11244 | 0.010 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 1985 | 794 | 0.010 |
Why?
|
| Remission Induction | 1 | 2004 | 2410 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 41754 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2001 | 693 | 0.010 |
Why?
|
| Carcinoembryonic Antigen | 1 | 1979 | 338 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2012 | 6283 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2011 | 6412 | 0.010 |
Why?
|
| Infant | 1 | 2019 | 36535 | 0.010 |
Why?
|
| Sepsis | 1 | 2011 | 2608 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2019 | 42669 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2008 | 9669 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2000 | 1760 | 0.010 |
Why?
|
| Hemolytic Plaque Technique | 1 | 1995 | 59 | 0.010 |
Why?
|
| Adolescent | 2 | 2019 | 89169 | 0.010 |
Why?
|
| Pyridines | 1 | 2007 | 2894 | 0.010 |
Why?
|
| Retinal Ganglion Cells | 1 | 2001 | 811 | 0.010 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1996 | 446 | 0.010 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2001 | 807 | 0.010 |
Why?
|
| Antigens, Bacterial | 1 | 1999 | 1150 | 0.010 |
Why?
|
| Mesentery | 1 | 1994 | 202 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2000 | 2089 | 0.010 |
Why?
|
| Skin Diseases | 1 | 1982 | 1085 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 30010 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1985 | 2195 | 0.010 |
Why?
|
| Young Adult | 2 | 2010 | 60066 | 0.010 |
Why?
|
| Calcimycin | 1 | 1992 | 214 | 0.010 |
Why?
|
| Cations, Divalent | 1 | 1992 | 167 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1992 | 305 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1992 | 341 | 0.010 |
Why?
|
| Echocardiography | 1 | 2005 | 5047 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 14729 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1992 | 826 | 0.010 |
Why?
|
| Child | 1 | 2019 | 80917 | 0.010 |
Why?
|
| Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1990 | 40 | 0.010 |
Why?
|
| Chemokine CCL1 | 1 | 1990 | 22 | 0.010 |
Why?
|
| Receptors, CCR8 | 1 | 1990 | 28 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2007 | 5703 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1990 | 775 | 0.010 |
Why?
|
| Chemokines, CC | 1 | 1990 | 286 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1990 | 525 | 0.010 |
Why?
|
| Annexins | 1 | 1989 | 40 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1989 | 342 | 0.000 |
Why?
|
| Cell-Free System | 1 | 1989 | 339 | 0.000 |
Why?
|
| Protein Denaturation | 1 | 1988 | 242 | 0.000 |
Why?
|
| Culture Media | 1 | 1990 | 898 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 1730 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 59629 | 0.000 |
Why?
|
| Viral Proteins | 1 | 1985 | 1802 | 0.000 |
Why?
|